The aim of this study was to identify risk factors for the development of hallucinations in
patients with Parkinson's disease (PD). A broad range of motor and nonmotor features was …

Nonmotor symptoms (NMS) are an important prodromal feature of Parkinson's disease (PD).
However, their frequency, treatment rates, and impact on health‐related quality of life …

Autopsy is the diagnostic gold standard for progressive supranuclear palsy (PSP). The N
ational I nstitute of N eurological D isorders and S troke and S ociety for P rogressive S …

BACKGROUND: Nonmotor symptoms (NMSs) are common in patients with Parkinson
disease (PD), but little is known about the burden of the full range of NMSs in de novo PD …

Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease. Traditionally, attention has focused on the motor symptomatology of …

Drug‐induced dyskinesia is a common phenomenon in Parkinson's disease (PD) and is
often socially as well as physically disabling for patients. The Movement Disorders Society …

The treatment of Parkinson's disease (PD) has revolved around pharmacologic interventions
that primarily treat the cardinal (dopaminergic) manifestations of tremor, rigidity, and …

This study compares the sensitivity of a Patient Questionnaire versus information gathered
by clinicians at a routine clinic visit in recognizing symptoms of wearing‐off in early …

The differential diagnosis of parkinsonian disorders is difficult, especially early in the course
of the diseases. The clinical subtypes of Parkinson's disease (PD) have not so far been …

In a recent study we identified abnormal salivation, dysphagia, nausea, constipation, and
defecatory dysfunction as those gastrointestinal (GI) symptoms associated with Parkinson …